首页> 外文期刊>The Egyptian Journal of Neurology, Psychiatry and Neurosurgery >Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study
【24h】

Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study

机译:嗜中性粒细胞淋巴细胞比和对Puillain-Barré综合征血浆的反应:一个前瞻性观察研究

获取原文
       

摘要

Guillain–Barré Syndrome (GBS) is one of the most severe neurological diseases that causes marked disability and even death. The aim of this study is to investigate the role of the neutrophil–lymphocyte ratio (NLR) as a prognostic marker for GBS and response to treatment with plasmapheresis. Seventy-five subjects (35 GBS patients and 40 healthy controls) were recruited. Complete general and neurological examinations were performed and Hughes disability scale score was evaluated for assessing functional motor deficits in GBS patients. In addition, NLR, erythrocyte sedimentation rate, and C-reactive protein level were calculated. NLR was significantly higher in GBS patients than in controls (p??0.001) and was significantly higher in axonal form than other demyelinating and mixed subtypes (p??0.02). Patients with a poor outcome had a significantly high NLR than patients with a good outcome (p?=?0.006). NLR was also positively correlated with Hughes disability scale score (p??0.001). The cut-off value for NLR to predict a good response of patients to plasmapheresis was ≤?4.4. NLR may be a rapid, simple, inexpensive biomarker for predicting the severity of GBS, outcome of patients, and their response to plasmapheresis.
机译:Guillain-Barré综合征(GBS)是最严重的神经系统疾病之一,导致患有明显的残疾甚至死亡。本研究的目的是探讨中性粒细胞淋巴细胞比(NLR)作为GBS的预后标志物的作用,以及用血浆丸治疗的反应。招募了七十五名受试者(35患者和40名健康对照)。进行完整的一般和神经学检查,并评估HUGHES残疾缩放评分以评估GBS患者的功能电机缺陷。另外,计算NLR,红细胞沉积率和C反应蛋白水平。 GBS患者中的NLR显着高于对照(P≤≤0.001),并且轴突形式明显高于其他脱髓鞘和混合亚型(p≤≤0.02)。患者较差的患者比患有良好结果的患者具有显着高的NLR(P?= 0.006)。 NLR也与Hughes残疾级别得分呈正相关(P?<0.001)。 NLR的截止值预测患者对血浆的良好反应≤≤4.4。 NLR可以是一种快速,简单,廉价的生物标志物,用于预测GBS,患者结果的严重程度及其对血浆疫苗的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号